Men
Tackling the issues men need to focus on to live their best life
-
Next generation therapy for men with mCRPC may extend survival
A medication designed to block and break down the androgen receptor, a key driver of prostate cancer growth, is being evaluated in a clinical trial at Providence Cancer Institute.
-
Behind the science: Celebrating our cancer research administrator
Get a behind the scenes peek into the work of a cancer research administrator as she reflects on her time at Providence Cancer Institute.
-
Charting new paths in treating ovarian cancer and recurring SCLC
Two new trials evaluating new medications or combinations of medications for people with ovarian cancer or small cell lung cancer open at Providence Cancer Institute.
- GET THE APP ›
-
The future of surgery is robotic, and it’s here
Robotic thoracic surgery is less invasive, allowing patients to recover more quickly. A Providence Cancer Institute surgeon calls it a game-changer.
-
Meet the 2025 cancer research interns
Hands-on experience in a laboratory at Providence Cancer Institute helps undergraduate students find their career path in biomedical fields.
-
Watch: Virtual health talk on understanding lung cancer
Learn key facts about lung cancer at a free virtual talk hosted by Providence Cancer Institute and Asian Cancer Resource & Support Services.
-
A new cancer therapy at Providence helps immune cells stand their ground
A new medication developed at Providence Cancer Institute is being evaluated in a clinical trial for people with advanced cancers.
-
Upper abdominal pain: Causes, symptoms and relief
Learn about upper abdominal pain causes, from gas to serious conditions. Know when to seek care and find relief options. Get expert guidance from Providence.
-
Personalized mRNA vaccine and next-gen immunotherapy: Two new cancer trials at Providence
Providence Cancer Institute is enrolling patients for two new immunotherapy trials targeting muscle-invasive urothelial cancer and advanced solid tumors.
- FIND A CLINIC ›
-
Clinical trials matter, just ask Randy
When Randy was diagnosed with small cell lung cancer, he thought it was time to get his affairs in order. But a phase I clinical trial at Providence Cancer Institute gave him more time and hope.
-
A comprehensive guide to men’s health
From cancer screenings to testosterone, explore this expert-backed guide from Providence covering key health topics every man should know.
-
Your summer health and safety guide
Stay safe this summer with Providence’s expert tips on sun protection, heat illness, injuries, autoimmune care and family wellness.
-
Healthier births start here: Join Providence Everett CenteringPregnancy
Discover the benefits of CenteringPregnancy at Providence Swedish Everett. Learn how this unique prenatal care model offers midwifery support in a group setting.
-
From life-saving surgery to back on the slopes: A photographer’s story
Gary tells his story about the difficult journey back to the slopes of Mt. Hood after receiving life-saving surgery for pancreatic cancer.
-
Signs Your Partner's New Year's Promises Are Just Empty Words
Discover the signs of healthy & toxic relationships and get help towards a better future with support from Providence's Intervention Center for Assault and Abuse (PICAA).
-
Providence Everett Honored for Excellence in Maternity Care
U.S. News & World Report named Providence Regional Medical Center Everett (PRMCE) a 2025 High Performing Hospital for Maternity Care.
-
A year to remember: Advancements, recognition and transitions
Catch the 2024 highlights from Providence Cancer Institute in this year-end recap focused on research advancements, caregiver recognition and community engagement.
-
CAR T cell-therapy, hope and healing: Dean’s story
Discover how Dean Lookingbill’s battle with lymphoma led him to CAR T-cell therapy at Providence Cancer Institute.
-
Providence Swedish North offers free STOP THE BLEED® training
Providence Swedish North is offering free STOP THE BLEED® training at Providence Regional Medical Center Everett.
-
Harnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma
New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.
-
Loading More...